# Emergent BioSolutions Inc.: Form 8-K, filed Aug 6, 2025

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2025-08-06
- Accepted by EDGAR: Aug 6, 2025, 16:13 ET
- Period: 2025-08-06
- Accession: 0001367644-25-000179
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764425000179/ebs-20250806.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764425000179/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764425000179/ebs-20250806.htm

Filed Aug 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001367644-25-000179. Last ingested by Listed: Nov 2, 2026, 16:45 ET. No prices; not investment advice.